查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1317823

转移性乳癌治疗市场：按治疗类型、最终用户划分 - 全球预测 2023-2030

Metastatic Breast Cancer Treatment Market by Treatment Type, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球转移性乳癌治疗市场将达216.6亿美元，复合年增长率为12.18%，大幅成长，预计2030年将达485.3亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球转移性乳癌治疗市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.转移性乳癌治疗的全球市场规模与预测为何？

2.在预测期内，COVID-19 对全球转移性乳癌治疗市场的阻碍因素和影响为何？

3.在预测期内，全球转移性乳癌治疗市场需要投资哪些产品/细分市场/应用/领域？

4.全球转移性乳癌治疗市场的竞争策略是什么？

5. 全球转移性乳癌治疗市场的技术趋势和法律规范是什么？

6.全球转移性乳癌治疗市场主要供应商的市占率是多少？

7. 哪些型态和策略性措施被认为适合进入全球转移性乳癌治疗市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 乳癌病例呈上升趋势
      • 提高大众对转移性乳癌治疗的认识
      • 抗电离辐射和紫外线
    • 抑制因素
      • 昂贵的转移性乳癌治疗方法
    • 机会
      • 癌症治疗领域的坚实技术进步
      • 转移性乳癌治疗的持续研究和开发
    • 任务
      • 与治疗相关的副作用
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章依治疗类型分類的转移性乳癌治疗市场

  • 生物标靶治疗
  • 乳房手术
  • 化学处理
  • 荷尔蒙治疗
  • 放射治疗

第7章转移性乳癌治疗市场：依最终用户分类

  • 诊所
  • 医院

第8章美洲转移性乳癌治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第9章亚太转移性乳癌治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲转移性乳癌治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第11章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第12章上市公司名单

第13章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-0363DFE03697

The Global Metastatic Breast Cancer Treatment Market is forecasted to grow significantly, with a projected USD 21.66 billion in 2023 at a CAGR of 12.18% and expected to reach a staggering USD 48.53 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Metastatic Breast Cancer Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Metastatic Breast Cancer Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Treatment Type, market is studied across Biologic Targeted Therapy, Breast Surgery, Chemotherapy, Hormone Therapy, and Radiation Therapy. The Biologic Targeted Therapy is projected to witness significant market share during forecast period.

Based on End User, market is studied across Clinics and Hospitals. The Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Metastatic Breast Cancer Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Metastatic Breast Cancer Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Metastatic Breast Cancer Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Metastatic Breast Cancer Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Metastatic Breast Cancer Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Metastatic Breast Cancer Treatment Market?

6. What is the market share of the leading vendors in the Global Metastatic Breast Cancer Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Metastatic Breast Cancer Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Metastatic Breast Cancer Treatment Market, by Treatment Type, 2022 vs 2030
  • 4.3. Metastatic Breast Cancer Treatment Market, by End User, 2022 vs 2030
  • 4.4. Metastatic Breast Cancer Treatment Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing cases of breast cancers
      • 5.1.1.2. Rise in awareness among people for metastatic breast cancer treatment
      • 5.1.1.3. Openness to ionizing and ultraviolet radiation
    • 5.1.2. Restraints
      • 5.1.2.1. Costly procedures of metastatic breast cancer treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust technological advancement in the cancer treatments
      • 5.1.3.2. Ongoing research and development in the metastatic breast cancer treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Side effect associated with the treatment
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Metastatic Breast Cancer Treatment Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Biologic Targeted Therapy
  • 6.3. Breast Surgery
  • 6.4. Chemotherapy
  • 6.5. Hormone Therapy
  • 6.6. Radiation Therapy

7. Metastatic Breast Cancer Treatment Market, by End User

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Hospitals

8. Americas Metastatic Breast Cancer Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Metastatic Breast Cancer Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Metastatic Breast Cancer Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. METASTATIC BREAST CANCER TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2030 (%)
  • FIGURE 5. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 6. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. METASTATIC BREAST CANCER TREATMENT MARKET DYNAMICS
  • FIGURE 8. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. METASTATIC BREAST CANCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. METASTATIC BREAST CANCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. METASTATIC BREAST CANCER TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BIOLOGIC TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BREAST SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HORMONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 11. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. METASTATIC BREAST CANCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 100. METASTATIC BREAST CANCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 101. METASTATIC BREAST CANCER TREATMENT MARKET LICENSE & PRICING